article · The Lancet Global Health
In September, world leaders will meet at the UN High-Level Meeting (UNHLM) on Antimicrobial Resistance (AMR).1 Drug-resistant tuberculosis is one of the major drivers of AMR-associated morbidity and mortality globally.2 The emergence and spread of AMR has set the tuberculosis response back decades. Advancement in research and political leadership, including through two UNHLMs on tuberculosis, have developed new pathways for progress in addressing tuberculosis.3 These efforts will be fatally undermined if governments fail to increase efforts to address AMR.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1016/s2214-109x(24)00229-8
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
